Search tips
Search criteria 


Logo of pharmscispringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSci. 2002 December; 4(4): 189–192.
Published online 2002 October 15. doi:  10.1208/ps040439
PMCID: PMC2751328

Introduction: A welcome to the first special animal health issue of AAPS PharmSci


The goal of this special volume is to provide veterinary scientists with state-of-the art reviews in animal health and to inform human health scientists of the various challenges and collaborative opportunities associated with their animal health counterparts. The contributors are highly respected experts, providing invaluable insights into current issues and state-of-the-art advances within veterinary medicine.

Keywords: Veterinary medicine, harmonization


1. Pharmaceutical Industry Primer 2001. Available at:
2. Ogilvie GK. Chemotherapy and the surgery patient: principles and recent advances. Clin Tech Small Anim Pract. 1998;13:22–32. doi: 10.1016/S1096-2867(98)80023-6. [PubMed] [Cross Ref]
3. Seksel K, Lindeman MJ. Use of clomipramine in treatment of obsessive-compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study. Aust Vet J. 2001;79:252–256. doi: 10.1111/j.1751-0813.2001.tb11976.x. [PubMed] [Cross Ref]
4. Pascoe PJ. Perioperative pain management. Vet Clin North Am Small Anim Pract. 2000;30:917–932. [PubMed]
5. Elliott J, Barber PJ, Syme HM, Rawlings JM, Markwell PJ. Management of cancer pain. Vet Clin North Am Small Anim Pract. 2000;30:951–966. [PubMed]
6. Elliott J, Barber PJ, Syme HM, Rawlings JM, Markwell PJ. Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract. 2001;42:122–129. doi: 10.1111/j.1748-5827.2001.tb02008.x. [PubMed] [Cross Ref]
7. Thiel-Cooper RL, Parrish FC, Sparks JC, Wiegand BR, Ewan RC. Conjugated linoleic acid changes swine performance and carcass composition. J Anim Sci. 2001;79:1821–1828. [PubMed]
8. Klindt J, Buonomo FC, Yen JT. Administration of porcine somatotropin by sustained-release implant: growth, carcass, and sensory responses in crossbred white and genetically lean and obese boars and gilts. J Anim Sci. 1995;73:1327–1339. [PubMed]
9. Cook RB, Popp JD, McAllister TA, Kastelic JP, Harland R. Effects of immunization against GnRH, melengestrol acetate, and a trenbolene acetate/estradiol implant on growth and carcass characteristics of beef heifers. Theriogenology. 2001;55:973–981. doi: 10.1016/S0093-691X(01)00458-7. [PubMed] [Cross Ref]
10. The State of World Fisheries and Aquaculture 2000. Rome, Italy: FAO; 2000. pp. 2000–2000.
11. Tidwell JH, Allan GL. Fish as food: aquaculture's contribution. Ecological and economic impacts and contributions of fish farming and capture fisheries. Eur Mol Biol Org Reports. 2001;2:958–963. [PubMed]
12. Shao ZJ. Aquaculture pharmaceutica and biologicals: current perspectives and future possibilities. Adv Drug Deliv Rev. 2001;50:229–243. doi: 10.1016/S0169-409X(01)00159-4. [PubMed] [Cross Ref]
13. PhRMA 2002: Backgrounder and Facts. 2002. Originally available at: html
14. Prescription drug products: Doxycycline and Penicillin G Procaine administration for inhalational anthrax (postexposure). Federal Register: November 2, 200, 66(213): 55679–55682 (Volume 66, Number 213).
15. Friedlander AM, Welkos SL, Pitt ML, et al. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis. 1993;167:1239–1243. [PubMed]
16. Draft Guidance for Industry: Clinical Development Programs for Drugs, Devices, and Biological Products Intended for the Treatment of Osteoarthritis (OA), dated 7/99. Available at:
17. Guidance for Industry: Clinical U.S. Department of Health and Human Services, CBER, CDRH, CDER, Chronic Cutaneous Ulcer and Burn Wounds—Developing Products for Treatment III. Preclinical Considerations, dated 6/00. Available at:
18. Points To Consider In The Preclinical Development Of Anti-Viral Drugs: CDER Guidance To Industry, dated 2/97. Available at:
19. Finerty S, Stokes CR, Gruffydd-Jones TJ, Hillman TJ, Barr FJ, Harbour DA. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus. Vaccine. 2001;20:49–58. doi: 10.1016/S0264-410X(01)00323-1. [PubMed] [Cross Ref]
20. Schandalik R, Gatti G, Perucca E. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. Arzneimittelforschung. 1992;42:964–968. [PubMed]
21. Holt S, Heading RC, Clements JA, Tothill P, Prescott LF. Acetaminophen absorption and metabolism in celiac disease and Crohn's disease. Clin Pharmacol Ther. 1981;30:232–238. [PubMed]
22. Juby LD, Rothwell J, Axon ATR. Cellobiose/mannitol test-a sensitive tubeless test for coeliac disease: results on 1010 unselected patients. Gut. 1980;30:476–480. doi: 10.1136/gut.30.4.476. [PMC free article] [PubMed] [Cross Ref]
23. Ullrich R, Zeitz M, Heise W, L_age M, Hoffken G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med. 1989;11L:15–21. [PubMed]
24. Plourde V. Stress-induced changes in the gastrointestinal motor system. Can J Gastroenterol. 1999;113(Suppl A):26A–31A. [PubMed]
25. Boyle R, Behan PO, Sutton JA. A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharmacol. 1990;30:405–409. [PMC free article] [PubMed]
26. Tizard I. Grease, anthraxgate, and kennel cough: a revisionist history of early veterinary vaccines. Adv Vet Med. 1999;41:7–24. doi: 10.1016/S0065-3519(99)80005-6. [PubMed] [Cross Ref]
27. Nordskog BA, Pham CT, Nutting DF, Tso P. An examination of the factors affecting intestinal lymphatic transport of dietary lipids. Adv Drug Deliv Rev. 2001;50:21–44. doi: 10.1016/S0169-409X(01)00147-8. [PubMed] [Cross Ref]
28. Edwards GA, Christopher JH, Caliph SM, Khoo SM, Charman WN. Animal models for the study of intestinal lymphatic drug transport. Adv Drug Deliv Rev. 2001;50:45–60. doi: 10.1016/S0169-409X(01)00148-X. [PubMed] [Cross Ref]
29. Yeh P-Y, Ellens H, Smith PL. Physiological considerations in the design of particular dosage forms for oral vaccine delivery. Adv Drug Deliv Rev. 1998;34:123–133. doi: 10.1016/S0169-409X(98)00036-2. [PubMed] [Cross Ref]
30. Federal Register (codified at §21CFR 520. 220b), April 1, 2002.

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists